Another meta‐analysis in 2011 including 17 studies also found that neither ERCC1 (rs3212986 and rs11615) nor ERCC2 (rs13181) was significantly associated with response and progression‐free survival in NSCLC patients 33. The gene discussed is ERCC1; the disease is non-small cell lung carcinoma.